OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammasomes: a rising star on the horizon of COVID-19 pathophysiology
Man Wang, Fei Yu, Wenguang Chang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15

Showing 15 citing articles:

Mechanistic insights from inflammasome structures
Jianing Fu, Kate Schroder, Hao Wu
Nature reviews. Immunology (2024) Vol. 24, Iss. 7, pp. 518-535
Closed Access | Times Cited: 50

Differences and similarities between innate immune evasion strategies of human coronaviruses
Helene Hoenigsperger, Rinu Sivarajan, Konstantin M. J. Sparrer
Current Opinion in Microbiology (2024) Vol. 79, pp. 102466-102466
Open Access | Times Cited: 8

Host mitochondria: more than an organelle in SARS-CoV-2 infection
Shahrzad Shoraka, Amali E. Samarasinghe, Amir Ghaemi, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 15

Exploring the Pathophysiology of Long COVID: The Central Role of Low-Grade Inflammation and Multisystem Involvement
Evgeni Gusev, Alexey Sarapultsev
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6389-6389
Open Access | Times Cited: 6

Induction of the Inflammasome by the SARS‐CoV‐2 Accessory Protein ORF9b, Abrogated by Small‐Molecule ORF9b Homodimerization Inhibitors
Erika Zodda, Mònica Pons, Natàlia DeMoya‐Valenzuela, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 2
Closed Access

Immunologic and inflammatory consequences of SARS-CoV-2 infection and its implications in renal disease
Hiam Naiditch, Michael R. Betts, H. Benjamin Larman, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access

Severe pediatric COVID-19: a review from the clinical and immunopathophysiological perspectives
Yikan Sun, Can Wang, Peiquan Lin, et al.
World Journal of Pediatrics (2024) Vol. 20, Iss. 4, pp. 307-324
Open Access | Times Cited: 4

Beyond acute infection: molecular mechanisms underpinning cardiovascular complications in long COVID
Roba Hamed Mostafa, Ahmed A. Moustafa
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 3

Inflammasome-Related Genetic Polymorphisms as Severity Biomarkers of COVID-19
Verónica Pulito‐Cueto, M. Sebastián Mora-Gil, Diego Ferrer‐Pargada, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3731-3731
Open Access | Times Cited: 3

Persistent Risk of Developing Autoimmune Diseases Associated With COVID-19
Shoichiro Inokuchi, Koji Shimamoto
JCR Journal of Clinical Rheumatology (2024) Vol. 30, Iss. 2, pp. 65-72
Open Access | Times Cited: 1

Dominant induction of the inflammasome by the SARS-CoV-2 accessory protein ORF9b, abrogated by small-molecule ORF9b homodimerization inhibitors
Erika Zodda, Mònica Pons, Natàlia DeMoya‐Valenzuela, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Immune Stimulation with Imiquimod to Best Face SARS-CoV-2 Infection and Prevent Long COVID
Ursino Pacheco-García, Elvira Varela-López, Jeanet Serafín‐López
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7661-7661
Open Access

The laboratory parameters in predicting the severity and death of COVID-19 patients: Future pandemic readiness strategies
Ahmad R. Alsayed, Syed Imran Ahmed, Anas Osama AL Shweiki, et al.
Biomolecules and Biomedicine (2023) Vol. 24, Iss. 2, pp. 238-255
Open Access | Times Cited: 1

Page 1

Scroll to top